No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.

ABSTRACT:

Purpose

To assess whether dysglycemia diagnosed during severe acute respiratory syndrome coronavirus 2 pneumonia may become a potential public health problem after resolution of the infection. In an adult cohort with suspected coronavirus disease 2019 (COVID-19) pneumonia, we integrated glucose data upon hospital admission with fasting blood glucose (FBG) in the year prior to COVID-19 and during postdischarge follow-up.

Methods

From February 25 to May 15, 2020, 660 adults with suspected COVID-19 pneumonia were admitted to the San Raffaele Hospital (Milan, Italy). Through structured interviews/ medical record reviews, we collected demographics, clinical features, and laboratory tests upon admission and additional data during hospitalization or after discharge and in the previ

SUBMITTER: Laurenzi A 

PROVIDER: S-EPMC8691144 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature